Piomelli, Daniele (2000). "Arachidonic Acid". Neuropsychopharmacology: The Fifth Generation of Progress. Diarkibkan daripada yang asal pada 2006-07-15. Dicapai pada 2006-03-03.
cyberlipid.org
Eicosanoids with different letters have placement of double-bonds and different functional groups attached to the molecular skeleton. Letters indicate roughly the order the eicosanoids were first described in the literature. For diagrams for PG [A–H] see Cyberlipid Center. "Prostanoids". Diarkibkan daripada yang asal pada 2007-02-08. Dicapai pada 2007-02-05.
"Cyclopentenone prostaglandins: new insights on biological activities and cellular targets". Medicinal Research Reviews. 21 (3): 185–210. 2001. doi:10.1002/med.1006.abs. PMID11301410.
"Multiple antioxidants in the prevention and treatment of Alzheimer disease: analysis of biologic rationale". Clinical Neuropharmacology. 23 (1): 2–13. 2000. doi:10.1097/00002826-200001000-00002. PMID10682224.
"Analysis of omega-3 and omega-6 fatty acid-derived lipid metabolite formation in human and mouse blood samples". Prostaglandins & Other Lipid Mediators. 94 (3–4): 81–7. 2011. doi:10.1016/j.prostaglandins.2010.12.006. PMID21236358.
"Quantification of intracellular and extracellular eicosapentaenoic acid-derived 3-series prostanoids by liquid chromatography/electrospray ionization tandem mass spectrometry". Prostaglandins, Leukotrienes, and Essential Fatty Acids. 91 (3): 61–71. 2014. doi:10.1016/j.plefa.2014.04.005. PMID24996760.
"Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases". J. Dent. Res. 82 (2): 82–90. 2003. doi:10.1177/154405910308200202. PMID12562878.
"Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis". Prostaglandins Other Lipid Mediat. 73 (3–4): 155–72. 2004. doi:10.1016/j.prostaglandins.2004.03.005. PMID15290791.
"Nutrigenomic approach to understanding the mechanisms by which dietary long-chain fatty acids induce gene signals and control mechanisms involved in carcinogenesis". Nutrition (Burbank, Los Angeles County, Calif.). 20 (1): 103–8. 2004. doi:10.1016/j.nut.2003.09.018. PMID14698023.
"Genetic variants in the metabolism of omega-6 and omega-3 fatty acids: their role in the determination of nutritional requirements and chronic disease risk". Experimental Biology and Medicine. 235 (7): 785–95. 2010. doi:10.1258/ebm.2010.009298. PMID20558833.
"15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂, an electrophilic lipid mediator of anti-inflammatory and pro-resolving signaling". Biochemical Pharmacology. 82 (10): 1335–51. 2011. doi:10.1016/j.bcp.2011.07.100. PMID21843512.
"5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease". Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1851 (4): 331–9. 2015. doi:10.1016/j.bbalip.2014.08.012. PMID25152163.
"Trimeric microsomal glutathione transferase 2 displays one third of the sites reactivity". Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1854 (10 Pt A): 1365–71. 2015. doi:10.1016/j.bbapap.2015.06.003. PMID26066610.
Bergström, S.; Danielsson, H.; Samuelsson, B. (1964). "The enzymatic formation of prostaglandin E2 from arachidonic acid". Biochim. Biophys. Acta. 90 (207): 207–10. doi:10.1016/0304-4165(64)90145-x. PMID14201168.
Vane, J. R. (June 23, 1971). "Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs". Nature New Biology. 231 (25): 232–5. doi:10.1038/newbio231232a0. PMID5284360.
University of Kansas Medical Center (2004). "Eicosanoids and Inflammation"(PDF). Diarkibkan daripada yang asal(PDF) pada 2005-05-16. Dicapai pada 2007-01-05.
"Cyclopentenone prostaglandins: new insights on biological activities and cellular targets". Medicinal Research Reviews. 21 (3): 185–210. 2001. doi:10.1002/med.1006.abs. PMID11301410.
"Multiple antioxidants in the prevention and treatment of Alzheimer disease: analysis of biologic rationale". Clinical Neuropharmacology. 23 (1): 2–13. 2000. doi:10.1097/00002826-200001000-00002. PMID10682224.
"Analysis of omega-3 and omega-6 fatty acid-derived lipid metabolite formation in human and mouse blood samples". Prostaglandins & Other Lipid Mediators. 94 (3–4): 81–7. 2011. doi:10.1016/j.prostaglandins.2010.12.006. PMID21236358.
"Quantification of intracellular and extracellular eicosapentaenoic acid-derived 3-series prostanoids by liquid chromatography/electrospray ionization tandem mass spectrometry". Prostaglandins, Leukotrienes, and Essential Fatty Acids. 91 (3): 61–71. 2014. doi:10.1016/j.plefa.2014.04.005. PMID24996760.
"Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases". J. Dent. Res. 82 (2): 82–90. 2003. doi:10.1177/154405910308200202. PMID12562878.
"Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis". Prostaglandins Other Lipid Mediat. 73 (3–4): 155–72. 2004. doi:10.1016/j.prostaglandins.2004.03.005. PMID15290791.
"Nutrigenomic approach to understanding the mechanisms by which dietary long-chain fatty acids induce gene signals and control mechanisms involved in carcinogenesis". Nutrition (Burbank, Los Angeles County, Calif.). 20 (1): 103–8. 2004. doi:10.1016/j.nut.2003.09.018. PMID14698023.
"Genetic variants in the metabolism of omega-6 and omega-3 fatty acids: their role in the determination of nutritional requirements and chronic disease risk". Experimental Biology and Medicine. 235 (7): 785–95. 2010. doi:10.1258/ebm.2010.009298. PMID20558833.
"15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂, an electrophilic lipid mediator of anti-inflammatory and pro-resolving signaling". Biochemical Pharmacology. 82 (10): 1335–51. 2011. doi:10.1016/j.bcp.2011.07.100. PMID21843512.
"5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease". Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1851 (4): 331–9. 2015. doi:10.1016/j.bbalip.2014.08.012. PMID25152163.
"Trimeric microsomal glutathione transferase 2 displays one third of the sites reactivity". Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1854 (10 Pt A): 1365–71. 2015. doi:10.1016/j.bbapap.2015.06.003. PMID26066610.
Bergström, S.; Danielsson, H.; Samuelsson, B. (1964). "The enzymatic formation of prostaglandin E2 from arachidonic acid". Biochim. Biophys. Acta. 90 (207): 207–10. doi:10.1016/0304-4165(64)90145-x. PMID14201168.
Vane, J. R. (June 23, 1971). "Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs". Nature New Biology. 231 (25): 232–5. doi:10.1038/newbio231232a0. PMID5284360.
Piomelli, Daniele (2000). "Arachidonic Acid". Neuropsychopharmacology: The Fifth Generation of Progress. Diarkibkan daripada yang asal pada 2006-07-15. Dicapai pada 2006-03-03.
Eicosanoids with different letters have placement of double-bonds and different functional groups attached to the molecular skeleton. Letters indicate roughly the order the eicosanoids were first described in the literature. For diagrams for PG [A–H] see Cyberlipid Center. "Prostanoids". Diarkibkan daripada yang asal pada 2007-02-08. Dicapai pada 2007-02-05.
University of Kansas Medical Center (2004). "Eicosanoids and Inflammation"(PDF). Diarkibkan daripada yang asal(PDF) pada 2005-05-16. Dicapai pada 2007-01-05.
